TSO3 Inc.

82 articles about TSO3 Inc.

• TSO3 Inc. Announces Completion of Arrangement

  10/1/2019

  TSO3 Inc. ("TSO3" or the "Company") (TSX: TOS) today announced that is has completed the previously-announced statutory plan of arrangement under the Business Corporations Act (Québec) pursuant to which a wholly-owned subsidiary of Stryker Corporation acquired all of the issued and outstanding common shares of the Company (the "Shares") for CAD$0.43 per share in cash (the "Arrangement"

• TSO3 Inc. announces receipt of final Court approval for Plan of Arrangement with Stryker

  9/26/2019

  TSO3 Inc. announced that the Superior Court of Québec issued a final order approving the previously-announced statutory plan of arrangement under the Business Corporations Act pursuant to which a wholly-owned subsidiary of Stryker Corporation will acquire all of the issued and outstanding common shares of the Company for CAD$0.43 per share in cash.

• TSO3 Inc. Confirms Purchase Price of CAD $0.43 per Share

  9/19/2019

  TSO3 Inc. ("TSO3" or the "Company") (TSX: TOS) confirms that the consideration payable to the shareholders of the Company (the "Shareholders") pursuant to the plan of arrangement (the "Arrangement") involving the Company, Stryker Corporation ("Stryker") and 9402-4874 Québec Inc. (the "Purchaser"), a subsidiary of Stryker, continues to be CAD $0.43 per share.

• TSO3 Inc. reminds shareholders to vote for the arrangement with Stryker

  9/12/2019

  TSO3 Inc. wishes to reiterate that shareholders should vote in favor of the proposed plan of arrangement involving the Company, Stryker Corporation ("Stryker") and 9402-4874 Québec Inc.

• TSO3 Inc. Announces the Filing of its Circular in Connection with the Special Meeting of Shareholders and Reminds Shareholders of the Key Reasons Why the Board Recommends Shareholders to Vote for the Arrangement with Stryker

  8/23/2019

  TSO3 Inc. ("TSO3" or the "Company") (TSX: TOS), announces today the filing of its management information circular (the "Circular") and related proxy materials with Canadian securities regulatory authorities in connection with the special meeting of shareholders (the "Special Meeting") to be held at 3:30 p.m.

• TSO3 Reports Second Quarter 2019 Results

  8/12/2019

  Revenues equaled $0.7 million, as compared to $1.0 million in the first quarter of 2019 and $0.4 million in the second quarter of 2018

• TSO3 Inc. Enters into Agreement to be Acquired by Stryker Corporation

  8/12/2019

  All amounts in this press release are in Canadian dollars unless otherwise specified.

• TSO3 Announces Group Purchasing Agreement with Capstone Health Alliance

  6/11/2019

  TSO3 Inc., an innovator in sterilization technology for medical devices in healthcare settings, is pleased to announce a preferred supplier agreement has been signed with Capstone Health Alliance, a group purchasing alliance representing close to 300 acute care facilities in 24 states across the United States.

• TSO3 Announces the Vote Results from its Annual Meeting of the Shareholders - May 8, 2019

  5/8/2019

  TSO3 Inc. announced that the nominees listed in the management proxy circular dated April 4, 2019, were elected as directors of TSO3.

• TSO3 Reports First Quarter 2019 Results

  5/6/2019

  TSO3 Inc. (TSX: TOS) ("TSO3" or the "Company"), an innovator in sterilization technology for medical devices in healthcare settings, reported financial results for the first quarter ended March 31, 2019.

• TSO3 Announces the Dates of its First Quarter 2019 Earnings Conference Call and Annual General Meeting of Shareholders

  4/30/2019

  TSO3 Inc. will hold a conference call to discuss its financial results for the first quarter ended March 31, 2019 and will hold its Annual General Meeting of Shareholders on Tuesday, May 7, 2019.

• TSO3 Reports Fourth Quarter and Full Year 2018 Results

  3/28/2019

  TSO3 Inc., an innovator in sterilization technology for medical devices in healthcare settings, reported financial results for the fourth quarter and year ended December 31, 2018.

• TSO3 Announces Date of Fourth Quarter and Full Year 2018 Earnings Conference Call

  3/21/2019

  TSO3 Inc., an innovator in sterilization technology for medical devices in healthcare settings, will hold a conference call on Thursday, March 28, 2019, to discuss its financial results for the fourth quarter and full year ended December 31, 2018.

• TSO3 Achieves Commercial Milestone and Provides Operational Update

  1/7/2019

  TSO3 Inc. announced that during its fourth fiscal quarter ending December 31, 2018, the Company received an order for the 100th unit of its industry-leading STERIZONE® VP4 Sterilizer

• American Journal of Infection Control publishes TSO3 study on terminal sterilization of duodenoscopes

  11/15/2018

  TSO3 Inc. announces today that the results of the Company's clinical in-use and simulated use testing of the terminal sterilization of duodenoscopes have been published in the American Journal of Infection Control.

• TSO3 Reports Third Quarter 2018 Results

  11/6/2018

  TSO3 Inc. reported financial results for the third fiscal quarter ended September 30, 2018.

• TSO3 Awarded Low Temperature Sterilization Contract pursuant to a Quebec Tender

  10/30/2018

  TSO3 Inc. announced that the Company has been awarded a sole-source contract relating to a low temperature sterilizer Request for Proposal (or tender) in the Province of Quebec for its STERIZONE® VP4 Sterilizers.

• TSO3 Named Winner of South Carolina Innovation Award

  10/29/2018

  TSO3 Inc. was named the winner of the South Carolina Chamber of Commerce's SC Branded Product Innovation Award.

• TSO3 Appoints Martin J. Madden to the Board of Directors

  8/29/2018

  TSO3 Inc. announced today that it has appointed Mr. Martin J. Madden to the Company's board of directors.

• UCHealth performs first patient procedure in Colorado using STERIZONE technology

  8/20/2018

  Cutting-edge system sterilizes duodenoscopes with low-temperature device